Comparative Study on Depigmenting Agents in Skin of Color.
Fitzpatrick IV/V skin type
Mexameter®
Skin lightening preparations
Journal
The Journal of clinical and aesthetic dermatology
ISSN: 1941-2789
Titre abrégé: J Clin Aesthet Dermatol
Pays: United States
ID NLM: 101518173
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
entrez:
21
3
2022
pubmed:
22
3
2022
medline:
22
3
2022
Statut:
ppublish
Résumé
Skin lightening agents are popular in southern Asia, but there is dearth of evidence on their effectiveness on Fitzpatrick IV/V skin types. This study was designed to assess the depigmenting efficacy of commercially available and specifically formulated ointments using the Mexameter This single center prospective study was performed to test five commercially available preparations (Eldopaque Significant hypopigmentation when compared to untreated controls was observed with Aziderm cream ( All applications containing active ingredients showed significant skin lightening; however, only arbutin was able to demonstrate significant diminution of pigmentation when compared to the inactive control.
Types de publication
Journal Article
Langues
eng
Pagination
12-17Informations de copyright
Copyright © 2022. Matrix Medical Communications. All rights reserved.
Déclaration de conflit d'intérêts
DISCLOSURES: The authors report no conflicts of interest relevant to the content of this article.
Références
J Invest Dermatol. 1984 Jun;82(6):623-8
pubmed: 6725985
Regul Toxicol Pharmacol. 2016 Feb;74:75-6
pubmed: 26646661
Indian J Dermatol Venereol Leprol. 2012 Jul-Aug;78(4):417-28
pubmed: 22772611
J Cosmet Dermatol. 2011 Dec;10(4):282-7
pubmed: 22151936
Pigment Cell Res. 2006 Dec;19(6):550-71
pubmed: 17083484
Dermatitis. 2014 Jan-Feb;25(1):e1-5
pubmed: 24407054
Inflamm Res. 2012 Aug;61(8):817-25
pubmed: 22487852
Dermatol Surg. 2005 Jul;31(7 Pt 2):886-9; discussion 889
pubmed: 16029683
J Cosmet Sci. 2014 Nov-Dec;65(6):365-75
pubmed: 25898763
Int J Toxicol. 2010 Nov-Dec;29(6 Suppl):244S-73
pubmed: 21164073
Br J Dermatol. 2002 Jul;147(1):20-31
pubmed: 12100180
J Dermatolog Treat. 2007;18(1):5-9
pubmed: 17365259
J Biol Chem. 2002 May 3;277(18):16340-4
pubmed: 11864987
J Am Acad Dermatol. 1996 Jan;34(1):29-33
pubmed: 8543691
J Drugs Dermatol. 2013 Jan;12(1):45-50
pubmed: 23377327
Bioorg Med Chem. 2012 Jan 15;20(2):1090-9
pubmed: 22189272
Cell Mol Life Sci. 2005 Aug;62(15):1707-23
pubmed: 15968468
Int J Dermatol. 1991 Dec;30(12):893-5
pubmed: 1816137
Biol Pharm Bull. 2013;36(11):1722-30
pubmed: 24189417
Dermatol Ther. 2007 Sep-Oct;20(5):308-13
pubmed: 18045355
Allergol Int. 2015 Apr;64(2):194-5
pubmed: 25838099
Dermatol Clin. 2003 Oct;21(4):743-9
pubmed: 14717415
Eur J Pharmacol. 2015 Oct 5;764:1-8
pubmed: 26118836
Contact Dermatitis. 2014 Jun;70(6):376-7
pubmed: 24846587
Int J Toxicol. 2010 Nov-Dec;29(6 Suppl):274S-87
pubmed: 21164074
Exp Dermatol. 2005 Aug;14(8):601-8
pubmed: 16026582
Biomol Ther (Seoul). 2014 Jan;22(1):35-40
pubmed: 24596619
Int J Toxicol. 2005;24 Suppl 2:51-111
pubmed: 16154915
J Cosmet Dermatol. 2012 Mar;11(1):65-71
pubmed: 22360337
Dermatol Res Pract. 2011;2011:379173
pubmed: 21822427
Dermatol Surg. 1996 May;22(5):443-7
pubmed: 8634807
Phytother Res. 2006 Nov;20(11):921-34
pubmed: 16841367
Dermatology. 2002;205(3):249-54
pubmed: 12399672
Free Radic Res. 2010 Apr;44(4):473-8
pubmed: 20166881
Skin Res Technol. 2000 Nov;6(4):230-238
pubmed: 11428962
J Drugs Dermatol. 2011 Jun;10(6):586-90
pubmed: 21637899
Skin Res Technol. 2006 Nov;12(4):298-302
pubmed: 17026663
Pigment Cell Res. 1998 Dec;11(6):355-61
pubmed: 9870547